Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
about
Exploiting Epigenetic Alterations in Prostate Cancer.Molecular mechanisms of Bdp1 in TFIIIB assembly and RNA polymerase III transcription initiation.Synthetic essentiality: Targeting tumor suppressor deficiencies in cancer.Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors.CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair.Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer.A partnership with the proteasome; the destructive nature of GSK3.The Chd1 Chromatin Remodeler Shifts Nucleosomal DNA Bidirectionally as a Monomer.β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.Post-translational Regulation of the RSF1 Chromatin Remodeler under DNA Damage.Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.tsRNA signatures in cancer.Human CHD1 is required for early DNA-damage signaling and is uniquely regulated by its N terminus.Overview on Clinical Relevance of Intra-Tumor Heterogeneity.Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification.Epigenetic Regulation in Prostate Cancer Progression.S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer.A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer.Genetics and biology of prostate cancerRecent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects
P2860
Q33755160-FF387EBF-FF36-41B7-8FE4-80A6ECC8D225Q38661551-CB8E253D-736A-43FF-871D-C95DCC1CB63EQ39413333-CCDB99F1-E762-48BE-827B-7BA8FB0A27A3Q46062200-CE74A751-867B-411F-A47F-2CE9587AE8B5Q46345647-B83C07B6-AAA0-4375-9AD1-D7F228122305Q47172196-7541C50A-1BCA-4863-B164-64F3C4B870C5Q47441648-96FF7078-105D-4C23-99A8-9ACBF8C465BBQ47751989-D174FE2E-16A6-45EA-8D0C-FA6C143CB0ABQ49357675-DAB305BA-3C1F-4388-9262-409815BA99BFQ49550769-29A7F1D3-2A88-4288-8D32-E151A6103E2EQ50026061-B94F39B2-0252-4E00-89FC-FC904FF2D1C0Q50897488-4B825A82-B0C7-447C-9F87-88EF19647FF2Q51741278-D1889158-8616-44CF-B82C-FF7A3AEFAEB4Q52313049-34FD7062-D4C1-4BC0-B0A6-235C9FC03C46Q52629153-E22F9CC0-45C3-4B80-A2E2-2BF4F8D6499BQ54974720-032CD383-C1AF-41E8-8846-5E381BB7FE9EQ54982486-C9E15842-2B90-4538-8608-E99C0B1B471CQ55042333-3C1F39FC-525C-4A95-ACFC-3F96D0930BCBQ57106917-76E7D6A9-E958-4C85-8550-757958C3EBFBQ57108205-4DBCE512-2B84-4D05-8E02-7BE27D886C7B
P2860
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
@en
type
label
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
@en
prefLabel
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
@en
P2093
P2860
P356
P1433
P1476
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
@en
P2093
Deepavali Chakravarti
Denise J Spring
Guocan Wang
Jasper Robin Chen
Jianhua Zhang
Nora M Navone
Patricia Troncoso
P2860
P2888
P304
P356
10.1038/NATURE21357
P407
P577
2017-02-06T00:00:00Z
P6179
1083550156